Columbus, OH –

Today, everything that can be tracked already is – or will be soon. So that begs the question, who does your data belong to? Is it yours, or does somebody else own it? If it’s yours, what are you doing with it? If it isn’t, what are they doing with it? With this flood of data, here are five things we should be asking.

s01

When sharing your sensitive personal data, what if it only existed for a few minutes, and then just disappeared? Is it time to think Snapchat for your personal health data?

s02

What if each individual owned all of their personal data and could grant or deny others “in the moment” access–easily turning it off and on?

s03

What if we created and shared our experiences, not just shared data? Connecting people, not just counted the number of steps they took?

s04

What if you had a personal area network? As you move so moves your data, allowing connections based on your physical location.

s05

What if we could deliver adaptable web/mobile services based on time or real-time data? Sunny outside? Google things to do and get outside results first.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.